O1-19-3Bmab+oral 5-FU therapy is appropriate for first-line treatment of elderly patients with ARCC

2016 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []